Jubilant Bhartia Group received $600 million from Goldman Sachs to acquire a 40 per cent stake in Coca-Cola's Indian bottling ...

SafeAir Certified Mold Inspection Inc., a trusted provider of mold testing and inspection services in Georgia, has published a new blog post aimed at educating homeowners about the hidden dangers of ...

Emrelis wins FDA approval, marking ABBV's first lung cancer drug and strengthening its oncology reach into solid tumors.

Huntington’s disease affects an estimated 5 to 10 per 100,000 people in most Western countries, with variation by region and ...

Merck, as it prepares a new version of its cancer blockbuster Keytruda, gets a boost in its patent dispute with Halozyme ...

Virtual chronic care provider Omada Health said on Thursday it had raised $150 million in its U.S. initial public offering, another sign of recovering investor appetite for new stocks.

In a report released on June 4, Dennis Ding from Jefferies maintained a Buy rating on Rhythm Pharmaceuticals, Inc.

Across the recent three months, 11 analysts have shared their insights on ACADIA Pharmaceuticals ACAD, expressing a variety ...

"attachment_1202489" align="aligncenter" width="1456"] A research scientist looking through a microscope in a lab, ...

The location at 250 Peabody Place is closed permanently, according to a statement sent by a company spokesperson on June 4, ...

Discover trends shaping the pharmaceutical sector. Get insights on rising prescription drug prices, supply chains, and growth ...

Bristol Myers Squibb and BioNTech to co-develop cancer immunotherapy BNT327 in a deal worth up to $11.1 billion.